SYNOX THERAPEUTICS UK LIMITED
Company number 13318557 · Monitor this company
Executive summary
Synox Therapeutics UK Limited is a pre-revenue biotechnology firm strategically positioned to advance a potentially best-in-class therapeutic in a niche oncology market. Its key strengths lie in valuable intangible assets, strong investor backing, and robust cash reserves secured through recent funding, enabling continued clinical development through 2026. However, significant financial liabilities, dependency on external funding, and inherent clinical risks require careful management to realize growth potential and transition successfully to commercial viability.
Shareholders' funds
£41,811,333
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-04-07
- Employees
- 8 (2024 accounts · was 6 in 2023)
- Registered office
- John Eccles House, Robert Robinson Avenue, Oxford, England, OX4 4GP
- Postcode
- OX4 4GP
- Accounts category
- Micro
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-04-06
- Next due by
- 2027-04-20
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current · 1 resigned
Contact details
- Website
- synoxtherapeutics.com
- Phone
- 03339005555
Among its peers
Top 5%
by shareholders' funds, of 179 similar companies in OX
Trading since 2021.
No.6 of the largest research and experimental development on biotechnology companies in Oxford →
Competitors Oxford
This company ranks 6 among research and experimental development on biotechnology in Oxford.